HomeCompareQDROD vs PFE

QDROD vs PFE: Dividend Comparison 2026

QDROD yields 6801.56% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QDROD wins by $1250738535048472.25M in total portfolio value
10 years
QDROD
QDROD
● Live price
6801.56%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1250738535048472.25M
Annual income
$1,215,581,436,672,994,400,000.00
Full QDROD calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — QDROD vs PFE

📍 QDROD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQDRODPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QDROD + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QDROD pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QDROD
Annual income on $10K today (after 15% tax)
$578,132.97/yr
After 10yr DRIP, annual income (after tax)
$1,033,244,221,172,045,200,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, QDROD beats the other by $1,033,244,221,172,045,200,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QDROD + PFE for your $10,000?

QDROD: 50%PFE: 50%
100% PFE50/50100% QDROD
Portfolio after 10yr
$625369267524236.13M
Annual income
$607,790,718,336,497,200,000.00/yr
Blended yield
97.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

QDROD
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QDROD buys
0
PFE buys
0
No recent congressional trades found for QDROD or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQDRODPFE
Forward yield6801.56%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$1250738535048472.25M$49.6K
Annual income after 10y$1,215,581,436,672,994,400,000.00$26,258.71
Total dividends collected$1248380634059638.00M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QDROD vs PFE ($10,000, DRIP)

YearQDROD PortfolioQDROD Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$690,856$680,156.44$9,153$693.39+$681.7KQDROD
2$44,654,212$43,914,995.45$8,593$849.25+$44.65MQDROD
3$2,700,574,973$2,652,794,966.49$8,336$1,066.78+$2700.57MQDROD
4$152,828,307,074$149,938,691,853.11$8,437$1,384.80+$152828.30MQDROD
5$8,093,605,100,498$7,930,078,811,928.28$9,013$1,875.40+$8093605.09MQDROD
6$401,153,174,213,425$392,493,016,755,892.20$10,306$2,680.72+$401153174.20MQDROD
7$18,610,175,790,400,972$18,180,941,893,992,610.00$12,820$4,101.38+$18610175790.39MQDROD
8$808,178,976,849,279,000$788,266,088,753,550,000.00$17,673$6,826.70+$808178976849.26MQDROD
9$32,857,101,285,493,140,000$31,992,349,780,264,415,000.00$27,543$12,591.86+$32857101285493.11MQDROD
10$1,250,738,535,048,472,200,000$1,215,581,436,672,994,400,000.00$49,560$26,258.71+$1250738535048472.25MQDROD

QDROD vs PFE: Complete Analysis 2026

QDRODStock

Quadro Resources Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. It holds 100% interests in the Staghorn gold property, the Costigan Lake property, and the Long Lake property located in west-central Newfoundland. The company also has an option to acquire a 100% interest in the Yellow Fox and Careless Cove properties situated in Newfoundland; and an option to acquire a 51% interest in the Tulks South property located in Newfoundland. In addition, it holds interest in the Conche property situated in the St. Anthony area on the Northern Peninsula, Newfoundland, and Labrador; and an option to acquire a 70% interest in the Seagull Lake property situated near Thunder Bay, Ontario. The company was formerly known as Tri-Gold Resources Corp. and changed its name to Quadro Resources Ltd. in May 2009. Quadro Resources Ltd. is headquartered in Vancouver, Canada.

Full QDROD Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this QDROD vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QDROD vs SCHDQDROD vs JEPIQDROD vs OQDROD vs KOQDROD vs MAINQDROD vs JNJQDROD vs MRKQDROD vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.